Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation

Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation

Conditions: Heart Failure; Inflammation
Interventions: Drug: Low Dose Colchicine; Drug: Placebo
Sponsors: University of Texas Southwestern Medical Center
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 14, 2023Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments